Vocabria

Vocabria (cabotegravir) is an antiretroviral medication used in HIV treatment and prevention. This intramuscular injection supports long-acting therapy for adults. A convenient option for those seeking extended-release HIV management. Suitable for use as prescribed by a healthcare provider.

Vocabria (cabotegravir) is used as part of combination therapy for HIV-1 infection in adults. It belongs to the integrase inhibitor class, helping to reduce viral load when taken as directed. The medication is also approved for pre-exposure prophylaxis (PrEP) to lower the risk of HIV infection in adults. It is typically used alongside other antiretrovirals for optimal effectiveness.

Cabotegravir works by blocking HIV integrase, an enzyme the virus needs to multiply. This helps maintain viral suppression over time when administered as prescribed. Patients may experience improved energy levels and reduced HIV-related symptoms with consistent use. The intramuscular injection provides steady medication release for long-term management.

Store cabotegravir injections at controlled room temperature, away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about all current medications and medical conditions before starting treatment. Follow disposal guidelines for used injection supplies to prevent accidental exposure.

Cabotegravir may interact with other medications that affect liver enzymes, such as certain anticonvulsants or rifamycins. Combining it with strong CYP3A inducers could reduce its effectiveness. Alcohol use should be discussed with a healthcare provider, as it may affect medication tolerance. Always review your full medication list with a professional.